We are proud to announce our collaborative project, formed by @Stream_Bio and @Chelsea_Tech, to develop an innovative rapid diagnostic platform for a range of targets, including #COVID19! 🌟
Read about the joint venture and our pioneering technology here: https://t.co/Jiu873IZ3h
We are Brightline Dx, a venture proudly developing a novel approach to #RapidDiagnostics, with exciting work ongoing in #healthcare, #COVID19 testing and more 🚀
Follow the link to learn more about our technology and mission: https://t.co/MALpC7tRWE
A new discovery could advance #LymeDisease#diagnostics and treatment! Scientists from @virginia_tech have discovered a unique bacterial property, which is a potential target for treating and diagnosing Lyme disease 👏 Read on: https://t.co/jb6IsBjkLA
Our novel #diagnostic platform, Claritas, has potential applications in numerous fields, including
#healthcare, rapid #COVID19 testing, #environmental monitoring 🏥🦠💧
Find out more about our technology here: https://t.co/9sXp8BZnTx
This #ThrowbackThursday we’re looking back at one of our recent @ChemistryWorld articles in the #Chemistry40 supplement!
Within, we discussed the need for improved #RapidDiagnostics, and how Brightline DX approached the challenge 🔬
Check it out: https://t.co/7zpkTTsMc1
Brightline DX takes great pride in being a member of @BIVDA, and supporting the fantastic work performed by our fellow members. Follow the link below to learn more about this #diagnostic innovation ⤵️
A UK graduate has launched a game-changing #endometriosis#diagnostics kit that tests ovulation health, egg reserves, nutritional deficiencies and detects hormonal conditions like PCOS.
Read about this great example of British diagnostic #innovation at: https://t.co/uYN5GlnYDr
Researchers from @OICR_news have revealed a catalogue of 166 prognostic #cancer biomarkers! 🌟 These biomarkers could improve the forecasting of patient outcomes to enhance treatment strategies. Read on in @Tech_Networks: https://t.co/AFxO6nuumF
Are you interested in learning more about the applications of our rapid #diagnostic platform? We’d be happy to discuss our technology and opportunities for collaboration 🤝 Get in touch with us here: https://t.co/lznwS5fupP
Check out this #LateralFlow time-lapse from our founding partner, @Stream_Bio! This impressively fluorescent #nanotechnology contributes to the sensitivity of our #diagnostic platform. Watch it in action below ⤵️
Researchers from @MethodistHosp have developed a model that could identify individuals who will benefit from #immunotherapy! By predicting the efficacy of treatment on an individual basis, this model could help to improve patient outcomes 🌟 Read on: https://t.co/hDLQZLphGt
Rapid, reliable and accessible #COVID19 testing remains a priority. Claritas was designed with these #diagnostic needs in mind ✅ Discover how we’re working to provide a novel point-of-care testing platform here: https://t.co/b001bKL4xX
Our novel rapid #diagnostic platform features a highly sensitive reader incorporating proven technology from @Chelsea_Tech! 🤩 Discover how Chelsea’s expertise in #environmental monitoring devices can be applied to the life sciences here: https://t.co/ocsP6VgMyX
Have you seen our news page? 📰 We want to keep you in the loop with our latest projects, collaborations and successes. Check out what we’ve been up to here: https://t.co/LFo3eCkqko
Thanks to the adaptable nature of our #diagnostic technology, we’re excited to explore new opportunities 🤩 From #environmental monitoring applications to different #healthcare targets, discover more about the potential of Claritas here: https://t.co/9sXp8BZnTx
It’s great to read about developments in #diagnostic techniques for rare disorders! Scientists from @Cambridge_Uni have used whole genome sequencing to detect 31% more cases of rare genetic disorders than standard tests 👏 Read on: https://t.co/rEgP0n4gck
We are proud to be a member of @BIVDA! 🌟 Our membership enables us to be part of key industry discussions and opens the way for new collaborations to develop our rapid #diagnostic technology. Learn more about BIVDA here: https://t.co/6J8bPPXTR3
It’s fascinating to learn how other areas of science can influence medical #diagnostics! Engineers from @UofT have developed a coating material with applications in #microfluidics, which could enhance ‘lab-on-a-chip’ technology 👏 Read on: https://t.co/Q2nbD9pEef
Detection sensitivity is a vital aspect of point-of-care #COVID19 testing. Our #diagnostic technology enables accurate detection of low viral loads, with similar sensitivity to PCR ✅ Find out more about how Claritas can enhance rapid #CovidTesting here:https://t.co/b001bKL4xX
It’s great to read about research that could prevent the spread of #superbugs! Researchers from @UniofNewcastle have developed a new testing method for wastewater to quantify the transmission of #AntimicrobialResistance 💧 Read on: https://t.co/Tk11ZBcDkc
Our #RapidDiagnostic platform, Claritas, was developed to address the need for point-of-care #COVID19 testing ⏩ Read about the challenges of current #diagnostic methods and how our technology could help in our @ChemistryWorld article: https://t.co/7zpkTTsMc1
Our #RapidDiagnostic platform unites innovative technology from founding partners @Stream_Bio and @Chelsea_Tech. Visit our ‘About’ page to discover how we aim to push the boundaries of in vitro #diagnostics ➡️ https://t.co/MALpC7tRWE